Fortune Brands Innovations FBIN Q1 2026 Earnings EPS Falls Just Short of Estimates Despite Strong Stock Reaction Actuate Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss Halliburton Q1 2026 Earnings Strong EPS Beat Amid Cautious Oilfield Services Outlook Nexalin Technology Inc NXL Q1 2026 Earnings EPS Misses Estimates as Stock Surges on No Revenue RNXT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Pathward Financial CASH Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly